How fatigue typically unfolds
Medication-related fatigue peaks in the first 1–3 weeks or after each dose increase — then fades as your body adjusts.
Wegovy
~6%
semaglutide trial
Zepbound
~5%
tirzepatide trial
Placebo
~3%
control group
Before assuming fatigue is a side effect, track your food for 3–5 days. Many people on GLP-1s eat only 600–800 cal/day without realising it. If so, the fix is eating more — not stopping the medication.
Is it the drug — or undereating?
When you eat significantly less than your body needs, it slows metabolism to conserve energy. The result is fatigue, brain fog, feeling cold, and low motivation. This is your body adapting to what it reads as a food shortage — not a drug side effect.
Signs it is undereating
- Eating under 1,000–1,200 calories a day
- Skipping meals because you are not hungry
- Getting under 60g of protein daily
- Feeling cold more often than usual
- Tiredness that gets worse, not better
- Difficulty concentrating (brain fog)
Signs it is the medication
- Started within days of first dose or dose increase
- Improves after 1–2 weeks at the same dose
- Happens even when you are eating enough
- Comes with nausea or other stomach symptoms
- Mild, not severe — more like low energy
When fatigue typically peaks
First 1–2 weeks
Your body is adjusting to a new hormone signal. Some tiredness is normal as your system recalibrates. This is the most common time for medication-related fatigue.
After each dose increase
Each step up can bring a brief wave of fatigue for a few days — mirroring the nausea pattern. It comes with the increase and fades as you adjust.
Weeks 4–8 (titration phase)
Fatigue here is more likely calorie-related than drug-related. Your body has adjusted to the medication but your eating may have dropped significantly.
After reaching maintenance dose
If fatigue persists for more than 6–8 weeks at a stable dose despite eating enough, talk to your doctor. They may check thyroid, iron, vitamin D, or sleep disorders.
What helps with fatigue
Most fatigue on weight loss medication responds to these six changes. Work through them before assuming the drug needs to change.
Eat enough — even when not hungry
Aim for at least 1,200 cal/day. Protein shakes, Greek yoghurt, and nuts help you reach minimums without forcing large meals.
Hit your protein target
Aim for 60–100g/day. Protein stabilises blood sugar, preserves muscle, and sustains energy — the last thing to cut when calories drop.
Stay hydrated
Dehydration causes fatigue fast. You lose ~20% of water intake when eating less food. Aim for 8+ glasses of water daily.
Protect your sleep
Aim for 7–9 hours. Poor sleep raises cortisol and ghrelin — making weight loss harder and fatigue worse.
Walk daily
Light activity (20–30 min walking) reduces fatigue more than it adds to it. Avoid intense exercise when calories are very low.
Check iron and vitamin D
Both deficiencies cause fatigue and are common when eating less. A simple blood test can check — supplements work within weeks if levels are low.
When to talk to your doctor
- Fatigue is severe — affecting your ability to work or function normally
- It has lasted more than 6–8 weeks at a stable dose despite eating enough
- You also have dizziness, shakiness, or confusion (possible low blood sugar)
- You are on insulin or sulfonylureas alongside a GLP-1
- You are sleeping 7+ hours but waking up exhausted
Bottom line
- Fatigue affects about 5–6% of people in studies — less common than nausea
- Most fatigue is from undereating, not the drug — track calories for 3–5 days to check
- It usually peaks in weeks 1–3 or after dose increases, then fades
- Six things help: calories, protein, water, sleep, light exercise, blood tests
Written and maintained by one person · Built with agentic AI tools · Every number checked against the cited trial · Not medical advice
Clinical data on fatigue as a side effect
Fatigue was reported as an adverse event in 5–11% of participants in GLP-1 clinical trials. In STEP 1 (semaglutide 2.4mg), fatigue was reported by about 6% of the active group. In SURMOUNT-1 (tirzepatide), fatigue rates were similar across dose groups at approximately 5%. In most cases, fatigue was mild to moderate and resolved without treatment discontinuation.
- STEP 1 — Semaglutide (injection): 1,961 adults with obesity or overweight with comorbidities, no type 2 diabetes, 68 weeks. New England Journal of Medicine, 2021. View source ↗
- SURMOUNT-1 — Tirzepatide: 2,539 adults with obesity or overweight with comorbidities, no type 2 diabetes, 72 weeks. New England Journal of Medicine, 2022. View source ↗
- ATTAIN-1 — Orforglipron: 3,127 adults with obesity or overweight with comorbidities, no type 2 diabetes, 72 weeks. New England Journal of Medicine, 2025. View source ↗
See how this applies to your medication
Next step most people take
Built with agentic AI tools and not a substitute for medical advice
Last reviewed: